PROCTER & GAMBLE HEALTH | SANDU PHARMA | PROCTER & GAMBLE HEALTH/ SANDU PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 52.1 | 66.4% | View Chart |
P/BV | x | 10.6 | 1.5 | 699.3% | View Chart |
Dividend Yield | % | 2.0 | 1.2 | 164.4% |
PROCTER & GAMBLE HEALTH SANDU PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
SANDU PHARMA Mar-23 |
PROCTER & GAMBLE HEALTH/ SANDU PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 86 | 6,239.1% | |
Low | Rs | 3,883 | 50 | 7,727.4% | |
Sales per share (Unadj.) | Rs | 740.7 | 67.6 | 1,095.0% | |
Earnings per share (Unadj.) | Rs | 138.2 | 1.6 | 8,779.4% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 2.1 | 7,358.2% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0.75 | 12,666.7% | |
Avg Dividend yield | % | 2.1 | 1.1 | 186.6% | |
Book value per share (Unadj.) | Rs | 447.6 | 40.6 | 1,101.9% | |
Shares outstanding (eoy) | m | 16.60 | 9.66 | 171.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 1.0 | 619.8% | |
Avg P/E ratio | x | 33.5 | 43.3 | 77.3% | |
P/CF ratio (eoy) | x | 29.8 | 32.3 | 92.2% | |
Price / Book Value ratio | x | 10.3 | 1.7 | 615.9% | |
Dividend payout | % | 68.7 | 47.6 | 144.3% | |
Avg Mkt Cap | Rs m | 76,761 | 658 | 11,663.0% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 111 | 1,858.2% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 653 | 1,881.6% | |
Other income | Rs m | 184 | 3 | 5,623.9% | |
Total revenues | Rs m | 12,480 | 657 | 1,900.3% | |
Gross profit | Rs m | 3,247 | 25 | 13,060.3% | |
Depreciation | Rs m | 281 | 5 | 5,435.2% | |
Interest | Rs m | 8 | 1 | 962.5% | |
Profit before tax | Rs m | 3,142 | 22 | 14,172.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 7 | 12,173.9% | |
Profit after tax | Rs m | 2,295 | 15 | 15,086.8% | |
Gross profit margin | % | 26.4 | 3.8 | 694.1% | |
Effective tax rate | % | 27.0 | 31.4 | 85.9% | |
Net profit margin | % | 18.7 | 2.3 | 802.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 255 | 4,585.2% | |
Current liabilities | Rs m | 6,791 | 139 | 4,891.4% | |
Net working cap to sales | % | 40.0 | 17.8 | 224.3% | |
Current ratio | x | 1.7 | 1.8 | 93.7% | |
Inventory Days | Days | 263 | 65 | 406.1% | |
Debtors Days | Days | 343 | 268 | 128.3% | |
Net fixed assets | Rs m | 10,617 | 286 | 3,709.5% | |
Share capital | Rs m | 166 | 97 | 171.8% | |
"Free" reserves | Rs m | 7,265 | 296 | 2,455.9% | |
Net worth | Rs m | 7,431 | 392 | 1,893.6% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 22,330 | 542 | 4,122.5% | |
Interest coverage | x | 409.1 | 28.7 | 1,425.3% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 1.2 | 45.6% | |
Return on assets | % | 10.3 | 3.0 | 349.0% | |
Return on equity | % | 30.9 | 3.9 | 797.0% | |
Return on capital | % | 42.4 | 5.9 | 724.4% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 13.1 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 1,605 | NA | - | |
Fx inflow | Rs m | 1,465 | 0 | - | |
Fx outflow | Rs m | 1,605 | 0 | - | |
Net fx | Rs m | -140 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 2 | 106,787.3% | |
From Investments | Rs m | -215 | 5 | -4,003.7% | |
From Financial Activity | Rs m | -985 | 6 | -17,006.9% | |
Net Cashflow | Rs m | 1,160 | 13 | 8,678.4% |
Indian Promoters | % | 0.0 | 42.9 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 0.0 | 199,700.0% | |
FIIs | % | 6.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 57.1 | 84.4% | |
Shareholders | 56,778 | 10,001 | 567.7% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | SANDU PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | -2.68% | 0.45% |
1-Month | -1.15% | 4.41% | 2.55% |
1-Year | 0.73% | 7.87% | 56.14% |
3-Year CAGR | -8.76% | 6.39% | 15.22% |
5-Year CAGR | 4.97% | 22.52% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the SANDU PHARMA share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of SANDU PHARMA the stake stands at 42.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of SANDU PHARMA.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
SANDU PHARMA paid Rs 0.8, and its dividend payout ratio stood at 47.6%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of SANDU PHARMA.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.